Teratogen-induced eye defects mediated by p53-dependent apoptosis

被引:64
作者
Wubah, JA [1 ]
Ibrahim, MM [1 ]
Gao, X [1 ]
Nguyen, D [1 ]
Pisano, MM [1 ]
Knudsen, TB [1 ]
机构
[1] JEFFERSON MED COLL,DEPT PATHOL ANAT & CELL BIOL,PHILADELPHIA,PA 19107
关键词
D O I
10.1016/S0960-9822(02)00422-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Many birth defects are believed to involve gene-environment interactions, although the mechanisms involved are poorly understood. Apoptosis is a common effect of many kinds of environmental stresses on the developing embryo; therefore, mechanisms of teratogenesis may be approached within the context of the cell death program. The p53 tumor suppressor gene encodes a transcription factor which functions as a critical regulator of apoptosis in response to environmental stress. Results: To investigate the relationship between p53-dependent apoptosis and teratogenesis, we subjected day 8 mouse embryos with different p53 gene backgrounds to a genotoxic stress, 2-chloro-2'-deoxyadenosine. Treatment rapidly stimulated nuclear p53 accumulation and triggered apoptosis in some (head-fold) but not other (primitive heart) developing structures. Induced cell death was p53 gene-dose dependent, as shown by the intermediate sensitivity of 4-5 somite stage embryos bearing only a single effective p53 allele and the lack of sensitivity of p53-null mutants, Abnormal development was manifested as eye defects by day 11, particularly lens agenesis. Overall the incidences of these defects at term were 73.3% for p53 wild-type fetuses, 52.5% for heterozygous mutants, and 2.2% for p53-null mutants. Statistical analysis indicated that the interaction between teratogen and genotype was highly significant (P less than or equal to 0.001) for cell death on day 8 and eye defects on day 17. Conclusions: We conclude that teratogen induction of p53-dependent apoptosis in the developing embryo is positively coupled to the determination of congenital eye defects.
引用
收藏
页码:60 / 69
页数:10
相关论文
共 47 条
[1]   HIGH-FREQUENCY DEVELOPMENTAL ABNORMALITIES IN P53-DEFICIENT MICE [J].
ARMSTRONG, JF ;
KAUFMAN, MH ;
HARRISON, DJ ;
CLARKE, AR .
CURRENT BIOLOGY, 1995, 5 (08) :931-936
[2]  
BENEVISTE P, 1995, P NATL ACAD SCI USA, V92, P8373
[3]   POTENT TOXICITY OF 2-CHLORODEOXYADENOSINE TOWARD HUMAN MONOCYTES INVITRO AND INVIVO - A NOVEL-APPROACH TO IMMUNOSUPPRESSIVE THERAPY [J].
CARRERA, CJ ;
TERAI, C ;
LOTZ, M ;
CURD, JG ;
PIRO, LD ;
BEUTLER, E ;
CARSON, DA .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (05) :1480-1488
[4]   ROLE OF APOPTOSIS IN MEDIATING PHOSPHORAMIDE MUSTARD-INDUCED RAT EMBRYO MALFORMATIONS IN-VITRO [J].
CHEN, BY ;
CYR, DG ;
HALES, BF .
TERATOLOGY, 1994, 50 (01) :1-12
[5]  
CHRISTENSEN N, 1976, ACTA PATHOL MICROB S, V254, P1
[6]  
CLARKE AR, 1994, ONCOGENE, V9, P1767
[7]   THYMOCYTE APOPTOSIS INDUCED BY P53-DEPENDENT AND INDEPENDENT PATHWAYS [J].
CLARKE, AR ;
PURDIE, CA ;
HARRISON, DJ ;
MORRIS, RG ;
BIRD, CC ;
HOOPER, ML ;
WYLLIE, AH .
NATURE, 1993, 362 (6423) :849-852
[8]   DEMONSTRATION OF DNA-DAMAGE REPAIR IN INDIVIDUAL CELLS USING IN-SITU END LABELING - ASSOCIATION OF P53 WITH SITES OF DNA-DAMAGE [J].
COATES, PJ ;
SAVE, V ;
ANSARI, B ;
HALL, PA .
JOURNAL OF PATHOLOGY, 1995, 176 (01) :19-26
[9]   MICE DEFICIENT FOR P53 ARE DEVELOPMENTALLY NORMAL BUT SUSCEPTIBLE TO SPONTANEOUS TUMORS [J].
DONEHOWER, LA ;
HARVEY, M ;
SLAGLE, BL ;
MCARTHUR, MJ ;
MONTGOMERY, CA ;
BUTEL, JS ;
BRADLEY, A .
NATURE, 1992, 356 (6366) :215-221
[10]  
FRITSCHE M, 1993, ONCOGENE, V8, P307